论文部分内容阅读
目的 :了解南京地区心血管系统药物的应用现状和发展趋势 ,为该类药物的研究、生产、销售和临床应用提供参考。方法 :采用南京地区19家医院1997年～2001年的心血管系统购药数据 ,按金额排序法进行分析。结果 :19家医院心血管系统用药金额5年内增长了2倍多 ,其中抗心绞痛及血管扩张药、抗血栓药、抗高血压药3个亚类用量 ,在5年内始终占据该大类药物的前3位。最近3年 ,钙拮抗剂已基本占据心血管系统用药的前3名。进口与合资药品占总量的综合比例 ,在二、三级医院中5年内基本稳定。结论 :心血管系统药物的市场需求潜力巨大 ,具备广阔的开发前景
Objective: To understand the current situation and development trend of cardiovascular system drugs in Nanjing area, and provide reference for the research, production, sales and clinical application of these drugs. Methods: The data of cardiovascular system purchase in 19 hospitals in Nanjing from 1997 to 2001 were analyzed by the method of sum of money. Results: The amount of cardiovascular system medication in 19 hospitals increased more than 2 times in five years. The dosage of anti-angina and vasodilator, antithrombotic and antihypertensive drugs accounted for 5 categories within 5 years Top 3. The last three years, calcium antagonists have basically occupied the top three cardiovascular system medication. The combined proportion of imported and joint-stock medicines accounted for the total amount was basically stable in secondary and tertiary hospitals in 5 years. Conclusion: The market demand for cardiovascular system drugs has great potential and has broad development prospects